As in the IMPACT trial, there was a dramatic improvement in skin disease with infliximab, with 60.2% of evaluable patients achieving a PASI75 by week 24 compared with just 1.1% of the placebo patients
Skip aspiration for subcutaneous shots it isnt needed [12]
Lenny Macrina: Right, and they talk about swelling, joint pain, anxiety, panic attacks, heart palpitations, insomnia, drowsiness, weakness, fatigue, loss of appetite, depression, anhedonia
Some practitioners prefer administering the dose post-workout or before sleep to align with natural healing and recovery processes
This approach emphasizes the critical role of researcher engagement in various activities including reading, writing, thinking, interpretation, argumentation, and justification
It captures chronic, lingering inflammation rather than acute spikes